C7ORF59 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.935400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.836600E-01
Normal-vs-Stage2
6.422200E-01
Normal-vs-Stage3
6.626000E-01
Normal-vs-Stage4
9.668800E-01
Stage1-vs-Stage2
8.591200E-01
Stage1-vs-Stage3
8.045200E-01
Stage1-vs-Stage4
8.252600E-01
Stage2-vs-Stage3
8.272800E-01
Stage2-vs-Stage4
6.433000E-01
Stage3-vs-Stage4
6.999000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.841200E-01
Normal-vs-AfricanAmerican
6.064400E-01
Normal-vs-Asian
9.743400E-01
Caucasian-vs-AfricanAmerican
8.304000E-01
Caucasian-vs-Asian
6.620000E-01
AfricanAmerican-vs-Asian
6.665200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.213400E-01
Normal-vs-Female
6.675400E-01
Male-vs-Female
5.567000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.322400E-01
Normal-vs-Age(41-60Yrs)
8.058400E-01
Normal-vs-Age(61-80Yrs)
5.854600E-01
Normal-vs-Age(81-100Yrs)
8.712400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.624800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.763950E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.487400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.159600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.050000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.150800E-01
Normal-vs-Daily Drinker
7.288600E-01
Normal-vs-Weekly Drinker
8.110000E-01
Normal-vs-Occasional Drinker
8.720400E-01
Normal-vs-Social Drinker
2.866600E-01
Non Drinker-vs-Daily Drinker
3.872300E-02
Non Drinker-vs-Weekly Drinker
5.561200E-01
Non Drinker-vs-Occasional Drinker
2.473800E-01
Non Drinker-vs-Social Drinker
8.077200E-01
Daily Drinker-vs-Weekly Drinker
2.981800E-01
Daily Drinker-vs-Occasional Drinker
9.251400E-01
Daily Drinker-vs-Social Drinker
2.107800E-02
Weekly Drinker-vs-Occasional Drinker
5.343800E-01
Weekly Drinker-vs-Social Drinker
4.622800E-01
Occasional Drinker-vs-Social Drinker
1.911970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.399000E-01
Normal-vs-Grade 2
4.521800E-02
Normal-vs-Grade 3
2.716600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.702000E-01
Grade 1-vs-Grade 3
7.629000E-01
Grade 1-vs-Grade 4
2.399000E-01
Grade 2-vs-Grade 3
8.051800E-01
Grade 2-vs-Grade 4
4.521800E-02
Grade 3-vs-Grade 4
2.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.738200E-01
Normal-vs-NonDiabetic
8.536800E-01
Diabetic-vs-NonDiabetic
3.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.498800E-01
Normal-vs-NoPancreatitis
7.500600E-01
Pancreatitis-vs-NoPancreatitis
2.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.914800E-01
Normal-vs-N1
6.340000E-01
N0-vs-N1
4.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.018200E-01
Normal-vs-TP53-NonMutant
4.548800E-01
TP53-Mutant-vs-TP53-NonMutant
3.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
